Subsequent examination of NKAIN2 protein expression by immunohistochemistry in 281 prostate cancer cases, including 161 cases from China and 120 cases from UK, revealed significant under-expression when compared to the adjacent normal tissues (p < 0.0001)(Table 1). The gene discussed is NKAIN2; the disease is prostate carcinoma.